Related Experiment Videos
Lymphocyte labeling with technetium-99m-HMPAO: a radiotoxicity study using the micronucleus assay
H M Thierens1, A M Vral, J P Van Haelst
1Department of Medical Physics, University of Gent, Belgium.
Summary
Cytogenetic radiation damage to lymphocytes from technetium-99m-hexamethylpropyleneamine oxime (99mTc-HMPAO) labeling was assessed. Self-irradiation damage was equivalent to 26 Gy of x-rays, but lymphoid malignancy risk is small due to impaired proliferation.
Area of Science:
- Cytogenetics
- Radiation Biology
- Nuclear Medicine
Background:
- In vitro labeling of leukocytes with 99mTc-HMPAO is common in nuclear medicine.
- Assessing radiation damage to lymphocytes post-labeling is crucial for patient safety.
Purpose of the Study:
- To evaluate cytogenetic radiation damage to lymphocytes after in vitro labeling with 99mTc-HMPAO.
- To quantify the radiation dose equivalent from self-irradiation during leukocyte labeling.
- To assess the risk of lymphoid malignancy following administration of labeled cells.
Main Methods:
- Cytokinesis-blocked micronucleus assay used to measure radiation damage.
- Isolated lymphocytes were studied across a range of intracellular activity concentrations.
- Comparison with x-ray dose-response curves for micronucleus incidence.
Main Results:
- Labeling leukocytes with 740 MBq of 99mTc-HMPAO caused significant impairment of proliferative capacity.
- Intracellular activity of 0-3 MBq/10(7) lymphocytes was studied.
- Estimated self-irradiation damage equivalent to 26 Gy of x-rays.
Conclusions:
- High levels of 99mTc-HMPAO labeling induce substantial radiation damage to lymphocytes.
- The observed inhibition of proliferative capacity at high doses suggests a small risk of lymphoid malignancy.
- Further research may be needed to optimize labeling procedures and minimize lymphocyte damage.